# Intuitive Surgical Q3 2026 Earnings Results

> Intuitive Surgical reports 22% revenue growth and 15% procedure expansion in Q3 2026.
- Title: Intuitive Surgical Q3 2026 Earnings Results · The Motley Fool
- Summary: Intuitive Surgical reports 22% revenue growth and 15% procedure expansion in Q3 2026. Intuitive Surgical reported $3.05 billion revenue with 15% procedure…
- Keywords: intuitive surgical, q3 2026, earnings call, da vinci 5, ion platform, sp platform, procedure growth, share repurchases, finance, money, Intuitive, Surgical
- Source: The Motley Fool — https://fool.com/earnings/call-transcripts/2026/10/21/intuitive-surgical-isrg-q3-2026-earnings-call-transcript
- Author: Motley Fool Transcribing
- Published: 2026-10-21T14:08:54+00:00
- Read time: 1 min
- Topics: intuitive surgical, q3 2026, earnings call, da vinci 5, ion platform, sp platform, procedure growth, share repurchases, finance, money
## Q3 2026 Results
Intuitive Surgical reported total revenue of $3.05 billion, up 22% from Q3 2025.
## Non-GAAP EPS
Non-GAAP EPS reached $3.00, a 25% year-over-year increase.
## Procedure Growth
Total procedure growth reached 15% with 14% da Vinci and 31% Ion growth.
## U.S. Da Vinci Growth
U.S. da Vinci procedures grew 10% year-over-year, consistent with expectations.
## International Da Vinci Growth
International da Vinci procedures grew 20% year-over-year, led by Europe and Japan.
## System Placements
546 da Vinci systems placed, up 28% from 427 units in Q3 2025.
## Da Vinci 5 Placements
315 da Vinci 5 systems placed, representing 58% of total da Vinci placements.
## Installed Base
13,246 total systems installed, up 13% year-over-year.
## I&A Revenue
I&A revenue grew to $1.80 billion, up 18% year-over-year.
## I&A Revenue Per Procedure
I&A revenue per procedure increased to $1,860 from $1,800 last year.
## Pricing Actions
3% to 5% reduction in I&A revenue per procedure expected from pricing actions.
## Operating Margin
Non-GAAP operating margin reached 42%, up from 41% excluding tariff refunds.
## Gross Margin
Non-GAAP gross margin at 69.9%, down from 68.9% excluding tariff refunds.
## SP Procedure Growth
SP procedures grew 55% globally, driven by 50% U.S. growth and 40% Korea growth.
## Ion Placements
56 Ion systems placed, up from 50 systems in Q3 2025.
## Share Repurchases
Share repurchases of $2.94 billion at $377 per share.
## Procedure Growth Guidance
Full year 2026 procedure growth guidance narrowed to 14% to 15%.
## Litigation Settlement
Agreed $450 million settlement for antitrust class action litigation.
## Ambulatory Surgery Centers
18 systems installed at U.S. ambulatory surgery centers.
## Cardiac Procedure Opportunity
300,000 to 400,000 annual cardiac procedures expected.
## Key takeaway

Intuitive Surgical reported $3.05 billion revenue with 15% procedure growth and $3.00 non-GAAP EPS for Q3 2026.